10 Best UK Penny Stocks to Watch in 2026

UK penny stocks are shares trading below £1 with a market capitalisation under £100 million, listed mainly on AIM or the London Stock Exchange main market. As of the 3 August 2026 close, examples include Kodal Minerals (0.30p, £61.12 million), Kromek Group (7.22p, £47.30 million) and Goldplat (17.25p, £29.63 million). All carry elevated volatility and liquidity risk.

Think of the London market as a football pyramid. The FTSE 100 is the Premier League: heavily scouted, exhaustively analysed, and rarely surprising, because thousands of professional eyes are on every player at once. UK penny stocks are the non-league clubs. Barely covered, cheap to buy into, occasionally producing someone who goes all the way, and far more often quietly folding in front of almost nobody. The absence of coverage is precisely what creates the opportunity and precisely what creates the danger.

This guide sets out what qualifies as a penny stock in the UK, applying both the price test and the market capitalisation test that most published lists ignore. It then works through ten AIM and LSE companies that pass both, each with its current price, market capitalisation, twelve-month performance, and the specific catalyst drawing attention. After that, it covers the benefits and the risks in detail, explains how to trade penny stocks UK step by step, and answers the questions traders ask most. The intention is to inform, not to advise on any specific trading decision.

Key Takeaways

• A UK penny stock must pass two tests: a share price below £1 and a market capitalisation below £100 million. Most published lists apply only the first.
• All prices, market capitalisations and performance figures in this guide are stated as of the 3 August 2026 close and will move.
• Applying both tests removes some well-known names. ITM Power (101.80p, £703.85 million) fails on price and size. NIOX Group (£254.10 million) and Pensana (£202.36 million) trade under £1 but are far too large to qualify.
• Failing on price alone is also possible. Hardide now trades at around 105.78p despite a market capitalisation of just £83.94 million, so it clears the size test but not the price test.
• Five of the ten companies covered are profitable. Kromek Group trades on a price-to-earnings ratio of 3.73 and The Parkmead Group on 3.08.
• Twelve-month moves in this segment are extreme in both directions. TPXimpact gained 241.5% while Eurasia Mining fell 41.9% over the same period.
• Wide bid-ask spreads, thin liquidity, and share dilution are structural features of this market, not occasional problems.

Penny Stocks UK: What They Are and How They Work

Penny stocks UK investors follow are low-priced shares in small companies. The conventional definition combines two criteria: a share price below £1 and a market capitalisation below £100 million. Both matter, and applying only the first is the single most common error in published penny stock lists.

The reason both are needed is that share price on its own describes nothing. A company can trade at 2.50p and be worth £73.79 million, as Eurasia Mining does, because it has 2.95 billion shares in issue. Another can trade at 61p and be worth £254.10 million, as NIOX Group does, on 420.7 million shares. NIOX is under £1 per share, but it is a mid-sized business with £48.70 million in revenue and a dividend. Calling it a penny stock tells a reader almost nothing useful about the risk they would be taking.

Market capitalisation, which multiplies share price by shares outstanding, is what actually describes company size. The £100 million ceiling exists because that is roughly where a company stops behaving like a micro-cap: analyst coverage begins, institutional buyers can build positions, and liquidity improves.

Typical characteristics of UK penny stocks include the following:

• A share price below £1, and often below 10p
• A market capitalisation below £100 million, and frequently below £30 million
• High volatility, with double-digit percentage moves on single announcements
• Thin liquidity and wide bid-ask spreads, meaning the cost of entering and exiting is high
• Limited analyst coverage, so information is patchy and reaches the market unevenly
• Frequent share issuance, because pre-revenue companies fund themselves by selling new shares

AIM vs LSE: Where UK Penny Stocks Actually Trade

Most UK penny stocks are on AIM, the LSE’s market for smaller companies, rather than the main market. AIM operates a lighter-touch regime: no minimum market capitalisation, no minimum free float, and no required trading record. Each AIM company must instead retain a nominated adviser, or nomad, and if that nomad resigns without replacement within a month, the shares are suspended and then cancelled.

Main market listings require a minimum free float, a trading history, and full compliance with the FCA Listing Rules. First Tin is one of the few genuine penny stocks listed there rather than on AIM.

Top 10 Penny Stocks UK to Watch in 2026

All figures are as of the 3 August 2026 close. Every company below trades under £1 with a market capitalisation under £100 million. Prices in this segment move quickly, so verify current data before acting on any of it.

Here are the 10 best penny stocks in the UK in detail, with company overviews, recent performance, and what to watch for each.

1. Kodal Minerals (KOD) – Lithium Producer in West Africa

Kodal Minerals is the most consistently discussed UK penny stock, and the reason is straightforward: it made the transition that almost no exploration company completes. Its Bougouni Lithium Project in southern Mali commissioned its Stage 1 Dense Media Separation plant in February 2025 and has since shipped multiple cargoes of spodumene concentrate, generating cumulative revenue of roughly $89 million.

At 0.30p, the shares sit in the lower half of a 0.22p to 0.62p twelve-month range, down 9.1% over the year, with a £61.12 million market capitalisation across 20.37 billion shares in issue. The company reported a net loss of £2.37 million.

What to watch: a Phase 2 flotation plant feasibility study is targeted for completion by the end of 2026, with an investment decision to follow. The share count is the key structural consideration, since 20.37 billion shares means any further equity raise dilutes existing holders meaningfully. Lithium pricing remains the dominant external variable.

2. Kromek Group (KMK) – Radiation Detection Technology

Kromek makes cadmium zinc telluride radiation detection technology used in medical imaging, nuclear security, and civil defence applications. It is a long-standing AIM company that spent years loss-making, which makes its recent results notable.

Trailing revenue reached £37.84 million, up 136.8%, with £12.50 million in net income. At 7.22p, the market capitalisation is £47.30 million, giving a trailing price-to-earnings ratio of 3.73, though the forward ratio of 19.68 implies the market expects that earnings level to normalise rather than repeat. The shares are up 38.9% over twelve months within a 4.70p to 13.00p range, across 655.14 million shares in issue.

What to watch: the gap between the trailing and forward earnings multiples is the whole debate. Elevated defence and nuclear security budgets are the demand driver, and analyst coverage carries a price target of 22.50p, though targets in this segment are wide of the mark as often as not.

3. Time Finance (TIME) – Specialist Lender

Time Finance provides asset finance, invoice finance, and business loans to UK small and medium-sized enterprises, a segment large banks have retreated from. It is unglamorous, and it is profitable.

Trailing revenue of £37.76 million rose 6.5%, with £6.07 million net income, up 14.8%, and earnings per share of 0.07, up 14.9%. At 51.50p and a £47.21 million market capitalisation across 91.68 million shares, the stock trades on a trailing price-to-earnings ratio of 7.85 and a forward ratio of 6.52. It is down 6.4% over twelve months within a 40.11p to 60.00p range.

What to watch: a single-digit earnings multiple on a growing, profitable lender is the value case. The risk is credit quality, since loan books deteriorate when small business insolvencies rise, and provisioning can move faster than revenue.

4. Goldplat (GDP) – Gold Recovery Operations

Goldplat recovers gold from the by-products of other miners’ operations, running plants in South Africa and Ghana. It is a processing business rather than an exploration company, which means it generates real revenue and has done for years.

Trailing revenue was £72.22 million, up 11.3%, with £2.88 million net income, down 35.1%. At 17.25p, the market capitalisation is only £29.63 million, well under half of annual revenue, on a trailing price-to-earnings ratio of 10.46, falling to a forward 6.12. The shares are up 155.6% over twelve months against a 5.85p to 21.00p range, and the company pays a small dividend yielding around 1.65%.

What to watch: the market capitalisation relative to revenue reflects the thin margins inherent in toll processing. Rising gold prices help, but jurisdictional risk across South African and Ghanaian operations is a permanent feature.

5. TPXimpact Holdings (TPX) – Public Sector Digital Transformation

TPXimpact delivers digital transformation services to UK public sector bodies, including central government departments, the NHS and local authorities. The company went through a difficult restructuring, and the recovery has been dramatic.

The shares are up 241.5% over twelve months, closing at 70.00p against a 52-week low of 13.62p, for a £65.45 million market capitalisation across 93.49 million shares. Trailing revenue was £78.10 million, up 1.0%, with a small net loss of £571,000 and a forward price-to-earnings ratio of 8.43.

What to watch: revenue is essentially flat while the share price has more than tripled, meaning the re-rating reflects margin repair and restored confidence rather than growth. At 70.00p the stock sits close to its 76.00p 52-week high, so much of the recovery is already priced in. Government IT spending decisions are the principal external risk, and public sector contracts are lumpy.

6. First Tin (1SN) – Tin Development in Germany and Australia

First Tin is developing tin projects in Saxony, Germany, and New South Wales, Australia, both in stable jurisdictions rather than the politically difficult regions that dominate global tin supply. Tin demand is driven by electronics soldering, and supply is concentrated in a small number of countries, which is the structural case for the company.

At 10.50p, the market capitalisation is £56.90 million across 541.87 million shares, up 79.5% over twelve months within a 5.60p to 19.00p range. The company reported a net loss of £1.35 million and has no revenue, being pre-production.

What to watch: this is a development-stage company, so the entire case rests on advancing projects to production, which requires capital. With no revenue, funding will come from equity issuance or project finance, and the former dilutes. Its main market listing, rather than AIM, is unusual for a company this size.

7. Eurasia Mining (EUA) – Platinum Group Metals

Eurasia Mining holds platinum group metals and gold assets, and it is included here because its situation illustrates something important about penny stock analysis. On the numbers, it looks reasonable: trailing revenue of £5.42 million with £4.45 million net income and a price-to-earnings ratio of 16.49, at 2.50p for a £73.79 million market capitalisation.

The shares are nonetheless down 41.9% over twelve months, sitting near the bottom of a 2.00p to 5.97p range, with 2.95 billion shares in issue.

What to watch: the company’s operations are Russia-focused, which brings sanctions exposure, currency convertibility problems, and difficulty repatriating cash regardless of what the reported figures show. The stock was also suspended in 2024 pending publication of audited accounts. Profitability on paper does not resolve geopolitical risk, and this is the clearest example on the list of why headline ratios need context.

8. The Parkmead Group (PMG) – Energy and Gas Assets

Parkmead holds North Sea and onshore Netherlands gas assets alongside renewable energy interests. At 21.50p, the market capitalisation is £23.49 million across 109.27 million shares, up 32.3% over twelve months within a 12.50p to 27.00p range.

The reported figures need care. Trailing revenue was £3.47 million, down 21.1%, yet net income was £7.63 million, up 154.3%, producing a price-to-earnings ratio of 3.08. Net income exceeding revenue by more than double indicates the profit came from asset revaluations or disposals rather than trading operations.

What to watch: that price-to-earnings ratio of 3.08 is not a signal of a cheap operating business, and reading it as one would be a mistake. The real questions are the value of the underlying gas assets, the cash position, and whether the renewable interests develop into anything material.

9. Cadence Minerals (KDNC) – Mining Investment Portfolio

Cadence Minerals holds stakes in mining projects rather than operating mines directly, with its most significant interest in the Amapá iron ore project in Brazil. This structure means its value is largely a function of how the underlying projects progress and how the market values them.

At 5.05p, the market capitalisation is £21.60 million across 427.63 million shares. The shares are up 173.0% over twelve months, the second-largest gain on this list, within a 1.77p to 8.30p range. The company reported negative revenue of £262,000 and a net loss of £1.71 million.

What to watch: negative reported revenue reflects accounting for investment holdings rather than an operating business, so conventional valuation measures do not apply. Progress at Amapá is the dominant variable, and holding-company structures add a layer between shareholders and the underlying assets.

10. ImmuPharma (IMM) – Clinical-Stage Biotechnology

ImmuPharma is a clinical-stage biotechnology company, with its lead programme historically focused on lupus. It is the highest-volatility name here, carrying a beta of 3.01, meaning it has moved roughly three times as much as the broader market.

At 3.90p, the market capitalisation is £24.33 million across 623.91 million shares, up 87.5% over twelve months. The 52-week range of 1.39p to 19.40p is the widest on this list by a considerable margin, and the current price sits at roughly a fifth of the high. The company has no revenue and reported a net loss of £1.81 million.

What to watch: clinical-stage biotech is genuinely binary. Trial results either succeed or they do not, and the share price reaction to each is severe in both directions. The fall from 19.40p to 3.90p within twelve months shows what the downside looks like in practice. Funding is required continuously until a product reaches market, which means recurring dilution.

Also on the Radar

Several other UK penny stocks pass both tests and appear regularly in screens: United Oil & Gas (UOG) at 0.1855p with an £8.58 million capitalisation across 4.64 billion shares; Petro Matad (MATD) at 1.00p and £17.52 million, focused on Mongolian oil; and Eco Buildings Group (ECOB) at 9.10p and £11.29 million, up 136.4% over twelve months.

Two others are worth knowing about as illustrations of how thin this market gets. MobilityOne (MBO) last traded at 6.75p on 30 June 2026, for a £7.18 million capitalisation, and its £235.70 million reported revenue is payment transaction flow rather than earnings. Windar Photonics (WPHO) last traded at 26.50p on 17 June 2026 for £25.63 million, down 53.9% over twelve months. Neither has changed hands in weeks, which is what illiquidity looks like in practice.

Top 10 UK Penny Stocks That Could Explode

Searches for the top 10 UK penny stocks that could explode are among the most common in this category, and the honest answer is that nobody can identify them in advance. What can be identified is which shares carry the characteristics associated with large moves: a very small market capitalisation, a binary catalyst, high beta, and a wide gap between the current price and either analyst targets or prior highs.

On current data, those are Kodal Minerals (analyst target of 0.92p, implying +207%); Kromek Group (target of 22.50p, implying +212%); ImmuPharma (52-week high of 19.40p, roughly five times the current price, with a beta of 3.01); Cadence Minerals (up 173.0% over twelve months); Petro Matad (52-week high of 1.675p, roughly 68% above the current price, on a £17.52 million capitalisation); First Tin (52-week high of 19.00p, roughly 80% above the current price); Eco Buildings Group (up 136.4% on an £11.29 million capitalisation); United Oil & Gas (sub-penny pricing on an £8.81 million capitalization); Goldplat (up 155.6% and profitable unlike most here); and TPXimpact (already up 241.5%).

The same characteristics work in reverse. Analyst targets on companies this size usually come from a single house; a 52-week high is evidence that a price was once reached rather than a forecast; and the shares most capable of rising 200% are the shares most capable of falling 80%. ImmuPharma’s fall from 19.40p to 3.90p is that mechanism running the other way.

Benefits of Trading or Investing in Penny Stocks

Penny stocks would not attract the attention they do without genuine advantages. These are the ones that hold up to scrutiny.

• Large percentage moves from a small capital base. A company worth £20 million needs far less new investment to double than one worth £20 billion. TPXimpact rose 241.5% and Cadence Minerals 173.0% over twelve months, moves that are effectively unavailable in the FTSE 100.
• Access to early-stage growth stories. Buying a company before it becomes widely followed is only possible while it is small. Kodal Minerals moved from exploration to production while capitalised at around £60 million, a transition that would normally occur inside a private company beyond the reach of retail investors.
• Genuine mispricing is more common. With little or no analyst coverage, information disseminates slowly and unevenly. Time Finance trading on a forward price-to-earnings ratio of 6.52 while growing earnings 14.8%, or Kromek on a trailing 3.73, are the kinds of discrepancies that rarely survive long in a well-covered large cap.
• Some are genuinely profitable businesses. The assumption that all penny stocks are speculative shells is wrong. Kromek generated £12.50 million net income, Time Finance £6.07 million, and Goldplat £2.88 million alongside a dividend. Profitable companies do trade below £1 with capitalisations under £100 million.
• Low capital requirements to build a position. A meaningful position can be established with modest capital, which allows diversification across several holdings rather than concentration in one.

Risks of Trading or Investing in Penny Stocks

The risks in this segment are structural rather than occasional. These are the seven that matter most.

• Total loss, suspension, and delisting. Craven House Capital was cancelled from AIM in 2025 after its nomad resigned over unpaid fees, leaving shareholders with an untradeable holding, and DP Aircraft I saw its equity wiped out after its lessee defaulted. On AIM, this is structural: if a nomad resigns and is not replaced within a month, the shares are suspended and then cancelled.
• Continuous share dilution. Pre-revenue companies fund themselves by issuing new shares, usually at a discount to the market price. Kodal Minerals has 20.37 billion shares in issue and Eurasia Mining 2.95 billion, and for a company with no revenue the next raise is a question of when rather than if.
• Poor liquidity and wide spreads. Thin order books mean selling quickly moves the price against you, and liquidity is worst precisely during the bad news that makes you want to sell. On a share quoted at 0.18p bid and 0.19p offer, the spread exceeds 5% of the price before the market has moved at all.
• Extreme volatility in both directions. ImmuPharma’s 52-week range spans 1.39p to 19.40p with a beta of 3.01, roughly three times market volatility. Eurasia Mining fell 41.9% across the same twelve months in which TPXimpact rose 241.5%.
• Reported figures can mislead. The Parkmead Group’s price-to-earnings ratio of 3.08 comes from £7.63 million net income on just £3.47 million of revenue, meaning the profit arrived through asset revaluations rather than trading. Eurasia Mining was profitable and still fell 41.9% because sanctions exposure does not show up in an earnings figure.
• Thin information and lighter governance. Most commentary on companies this size comes from bulletin boards and promotional sources with undisclosed positions, and genuinely independent research is rare. AIM’s lighter regime also means less oversight, smaller audit firms, and fewer independent directors.
• Everything rests on one catalyst. Most penny stock theses depend on a single event: a feasibility study, a clinical readout, or a contract award. Kodal Minerals hinges on its Phase 2 decision and ImmuPharma on trial results, and when the event disappoints, there is no diversified business underneath to absorb it. Sector concentration compounds this, since UK penny stocks cluster heavily in mining and energy.

How to Trade Penny Stocks UK: A Step-by-Step Approach

Anyone researching how to trade penny stocks in the UK will find plenty of enthusiasm and very little process. The steps below describe a disciplined approach.

1. Decide Whether You Are Trading or Investing

These require different methods. Investing means buying shares outright and holding through volatility for a company-specific thesis to play out, potentially across years. Trading means taking shorter-term positions on price movement, often using derivatives, with defined exit points. Confusion between the two is how a short-term trade quietly becomes an unplanned long-term holding.

2. Check Both the Price and the Market Capitalisation

Confirm the share is trading under £1 and that the company is capitalised under £100 million. This takes seconds and immediately tells you whether you are looking at a genuine micro-cap or at a mid-sized business with a low share price, which are entirely different risk propositions.

3. Verify the Listing Status

Confirm the company is currently trading, not suspended, and that its nomad is in place. This single check would have excluded Craven House Capital from consideration. The company’s RNS announcement history is the authoritative source.

4. Research the Fundamentals, Not the Share Price

Establish market capitalisation, shares in issue, trailing revenue, profit or loss, and cash position. Trace any reported profit back to its source, because asset revaluations and operating profits are not the same thing. For loss-making companies, the key question is how many months of cash remain at the current burn rate, since that determines when the next dilutive fundraise arrives.

5. Understand the Specific Catalyst and Its Timing

Most penny stock theses depend on a discrete event: a feasibility study, a production decision, a drilling result, a contract award, or a clinical trial readout. Identify what the event is, when it is expected, and what happens to the share price if it disappoints. Kodal Minerals’ Phase 2 feasibility study, targeted for the end of 2026, is a clear example.

6. Check the Spread and Daily Volume Before Committing

Look at the actual bid and offer, not the mid price, and calculate the spread as a percentage. Review average daily volume and ask whether your intended position could be exited in a single day without moving the market. If it could not, the position is too large.

7. Choose a Regulated Platform and Confirm the Instrument Is Available

Not every broker offers every AIM micro-cap, and coverage of sub-penny shares in particular varies considerably between providers. Confirm the specific company is available on your chosen platform before building a strategy around it, and check the commission, custody, and financing costs that apply.

8. Size Positions on the Assumption of Total Loss

Because permanent loss is realistic in this segment, position sizing matters more than entry timing. A common approach is to limit any single penny stock to a small percentage of the overall portfolio, chosen so that a complete write-off is survivable.

9. Set Exit Levels in Advance and Use Risk Management Tools

Decide on both a stop level and a target before entering. Stop-loss and take-profit orders help enforce this, though standard stop-losses can suffer significant slippage in illiquid shares and may fill well below the trigger. Guaranteed stops, where available, remove that gap for a fee.

10. Monitor RNS Announcements Continuously

Penny stocks re-rate on single announcements. Set alerts for regulatory news on every holding. In a market with thin coverage, the RNS feed is often the only timely source of material information.

New to trading? Learn how to start trading for beginners. 

Who Should Consider Trading UK Penny Stocks?

This segment suits a narrow group of people, and it is worth being direct about who they are.

It may be appropriate for experienced investors with a diversified core portfolio who allocate a small, defined proportion to higher-risk positions, who can read company accounts independently, and who can genuinely absorb a total loss on any individual holding without it affecting their financial position.

It is unlikely to be appropriate for anyone investing money they may need within a few years, anyone building a first portfolio, anyone relying on tips or forum sentiment rather than primary research, or anyone who would struggle to hold a position through a 50% drawdown, which is an ordinary rather than exceptional event here.

Practical Tips for Trading UK Penny Stocks

• Check the market capitalisation, not just the share price. It is the fastest way to tell a genuine micro-cap from a mid-cap with a low share price.
• Read the RNS history before the share price chart. The announcements explain the chart.
• Count the shares in issue. A rising share count over successive years is the clearest dilution signal.
• Trace reported profits to their source. Net income larger than revenue means the profit did not come from trading.
• Calculate the cash runway. Divide cash on hand by quarterly operating outflow; a short runway means a fundraise is coming.
• Be sceptical of promotional coverage. Enthusiastic articles on small caps are frequently commissioned.
• Treat 52-week highs as history, not targets. ImmuPharma’s 19.40p high did not prevent a fall to 3.90p.
• Watch director dealings. Directors buying with their own money is among the more meaningful signals available.
• Use limit orders rather than market orders. In wide-spread shares, a market order can fill at a materially worse price.
• Avoid averaging down reflexively. Adding to a falling position increases exposure to a thesis the market is rejecting.
• Diversify across sectors, not just tickers. Ten mining companies is one bet, not ten.

Conclusion

UK penny stocks in 2026 present a genuinely mixed picture. Several of the companies covered here are profitable and cash-generative, trading on modest earnings multiples: Kromek at a trailing price-to-earnings ratio of 3.73, Time Finance at 7.85, and Goldplat at 10.46. Others are pre-revenue development or clinical-stage stories where the entire case depends on a future event and where dilution is ongoing.

The twelve-month performance spread, from TPXimpact at +241.5% to Eurasia Mining at -41.9%, captures the essential character of this market better than any general description. Both outcomes came from the same segment, over the same period, and neither was reliably predictable at the start of it.

Applying the market capitalisation test alongside the price test is the single most useful discipline available here, and it is the one most commonly skipped. It removes companies such as NIOX Group, which trades under £1 but is capitalised at £254.10 million, and keeps attention on the companies where micro-cap dynamics genuinely apply.

Beyond that, what separates a considered approach from speculation is process: verifying listing status, reading the accounts, tracing where profits came from, understanding the catalyst and its timing, checking the spread, sizing positions on the assumption of total loss, and setting exits in advance. That process will not identify the next ten-bagger. It will keep a portfolio intact while looking.

Trade UK and Global Shares with VT Markets

VT Markets is a regulated multi-asset broker offering access to more than 1,000 instruments across forex, indices, precious metals, shares, ETFs, cryptocurrencies, and bonds. While investors researching UK penny stocks are often looking for high-growth opportunities, many traders also broaden their market exposure by analysing a wider range of UK and global share CFDs available through VT Markets.

Whether you’re exploring new trading opportunities or refining an existing strategy, you can practise in a risk-free environment with a demo account. Traders can access the markets through MetaTrader 4 (MT4), MetaTrader 5 (MT5), and the VT Markets App, while the VT Markets Help Centre provides platform guides, educational resources, and account support whenever needed.

Open your VT Markets account today and access a wide range of UK and global market opportunities.

Risk warning: Penny stocks are highly volatile and illiquid, and you may lose your entire investment. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any security. Past performance is not a reliable indicator of future results. All prices and figures are stated as of the 3 August 2026 close and will change. Consider your investment objectives and risk tolerance, and seek independent financial advice if necessary.

Frequently Asked Questions (FAQs)

1. What are penny stocks UK investors typically trade?

UK penny stocks are shares priced below £1 with a market capitalisation below £100 million, most commonly listed on AIM rather than the London Stock Exchange main market. They typically have limited analyst coverage, wide bid-ask spreads, and high volatility. Examples as of 3 August 2026 include Kodal Minerals at 0.30p with a £61.12 million capitalisation and Kromek Group at 7.22p with £47.30 million.

2. What market cap counts as a penny stock in the UK?

The conventional UK threshold is a market capitalisation below £100 million, applied alongside a share price below £1. Both tests matter. A company trading at 61p with a £254 million capitalisation, as NIOX Group does, meets the price test but is a mid-sized business rather than a micro-cap. Checking market capitalisation is the fastest way to tell the difference, and most published penny stock lists skip it.

3. What are the 10 best penny stocks UK traders are watching in 2026?

UK penny stocks meeting both the price and market capitalisation tests that are widely watched in 2026 include Kodal Minerals (KOD), Kromek Group (KMK), Time Finance (TIME), Goldplat (GDP), TPXimpact (TPX), First Tin (1SN), Eurasia Mining (EUA), The Parkmead Group (PMG), Cadence Minerals (KDNC), and ImmuPharma (IMM). These span lithium, radiation detection, lending, gold recovery, digital services, tin, platinum group metals, energy, mining investment, and biotechnology. Being widely watched is not the same as being suitable for any particular investor.

4. What are the top 10 UK penny stocks that could explode?

No one can identify in advance which penny stocks will rise sharply. Shares carrying the structural characteristics associated with large moves include Kodal Minerals, Kromek Group, ImmuPharma, Cadence Minerals, Petro Matad, First Tin, Eco Buildings Group, United Oil & Gas, Goldplat, and TPXimpact, based on analyst targets, distance from 52-week highs, small capitalisations and high beta. The same characteristics make severe losses equally possible. ImmuPharma rose 87.5% over twelve months but still trades at roughly a fifth of its 19.40p 52-week high.

5. How do I trade penny stocks in the UK as a beginner?

Start by deciding whether you are investing in shares outright or trading derivatives. Then work through a fixed checklist: check both the share price and the market capitalisation, verify the company is currently listed and not suspended, research its accounts and cash runway, identify the specific catalyst and its timing, check the bid-ask spread and daily volume, choose a regulated platform that carries the instrument, size the position assuming total loss is possible, and set stop-loss and take-profit levels before entering. Practising on a demo account first is sensible.

6. Are UK penny stocks a good investment?

They are high-risk and suit only a small portion of a diversified portfolio, if any. Some are profitable businesses on low earnings multiples, such as Kromek Group at a trailing price-to-earnings ratio of 3.73 or Time Finance at 7.85. Others are pre-revenue companies that dilute shareholders continuously and may fail entirely. Craven House Capital was delisted from AIM in 2025, leaving shareholders unable to trade. Suitability depends on your risk tolerance, time horizon, and ability to absorb a total loss.

7. What is the difference between AIM and LSE penny stocks?

AIM is the London Stock Exchange’s market for smaller companies and operates a lighter-touch regime with no minimum market capitalisation, no minimum free float, and no required trading record. Each AIM company must retain a nominated adviser, and if that nomad resigns without replacement within a month, the shares are suspended and cancelled. Main market listings require a minimum free float, a trading history, and compliance with the full FCA Listing Rules. Most UK penny stocks are on AIM, though First Tin is a main market example.

8. Can penny stocks be held in an ISA?

Yes. Shares listed on AIM and the main market can generally be held within a stocks and shares ISA, sheltering gains and dividends from UK tax. Many AIM shares held for at least two years have also historically qualified for Business Relief from inheritance tax, though eligibility varies by company and reliefs change. Confirm current treatment with a qualified tax adviser.

9. How much money do I need to start trading penny stocks in the UK?

Capital requirements are low, and this is part of the appeal, but the more relevant question is how much you can afford to lose entirely. Because permanent loss is a realistic outcome, position sizing matters more than the starting balance. A common approach limits any single penny stock to a small percentage of a broader portfolio.